1Stock1.com

Trius Therapeutics, Inc. (TSRX) Yearly Returns

Year	Beginning Price	Ending Price	Gain or Loss	Percent Gain or Loss
2011	3.71	7.15	3.44	92.72%
2012	7.15	4.78	-2.37	-33.15%
2013	4.78	13.50**	8.72	182.43%

**In 2013, Cubist Pharmaceuticals acquired Trius Therapeutics for $13.50 per share.

Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).

Disclaimer/Contact Us

Stock Performance Guide         

Yearly Stock Returns Index     

Back to Yearly Stock Returns Index

Articles
From
1stock1.com